Niagen Bioscience, Inc. SEC filings NAGE
Niagen Bioscience, Inc. has 981 filings in SEC EDGAR's recent list, going back to Jan 18, 2007. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 4, 2026 | Aug 4, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 29, 2026 | — |
| 424B5 | Prospectus supplement | Jul 10, 2026 | — |
| EFFECT | Filing | Jul 9, 2026 | — |
| 4 | Insider transaction | Jul 8, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 29, 2026 | Jun 24, 2026 |
| S-3 | Shelf registration | Jun 29, 2026 | — |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2026 | May 6, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 24, 2026 |
| 8-K |
Current report
Other events
|
Mar 19, 2026 | Mar 19, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 4, 2026 | Mar 4, 2026 |
| 10-K | Annual report | Mar 4, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 26, 2026 | Feb 24, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 19, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 30, 2026 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 22, 2025 | Dec 18, 2025 |
| 4 | Insider transaction | Nov 17, 2025 | Nov 14, 2025 |
| 8-K |
Current report
Other events
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2025 | Nov 4, 2025 |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 31, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 6, 2025 | Oct 6, 2025 |
| S-8 | Employee stock plan registration | Aug 8, 2025 | — |
| S-8 | Employee stock plan registration | Aug 8, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2025 | Aug 6, 2025 |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement
|
Jul 29, 2025 | Jul 25, 2025 |
| 4 | Insider transaction | Jul 3, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 27, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 25, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 25, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 25, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 25, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2025 | May 7, 2025 |
| 10-Q | Quarterly report | May 7, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Apr 9, 2025 | Apr 9, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 19, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 7, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 4, 2025 | Mar 4, 2025 |
| 10-K | Annual report | Mar 4, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Feb 27, 2025 | Feb 25, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 27, 2025 | Feb 25, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| 8-K |
Current report
Auditor change
|
Dec 16, 2024 | Dec 13, 2024 |
| 4 | Insider transaction | Dec 13, 2024 | Dec 13, 2024 |
| 144 | Notice of proposed sale | Dec 13, 2024 | — |
| 8-K |
Current report
Other events
|
Dec 4, 2024 | Dec 4, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 22, 2024 |
| 424B3 | Prospectus | Nov 21, 2024 | — |
| 8-K |
Current report
Material agreement
|
Nov 21, 2024 | Nov 20, 2024 |
| 3 | Initial insider ownership | Nov 8, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 31, 2024 | Oct 31, 2024 |
| 10-Q | Quarterly report | Oct 31, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Oct 23, 2024 | Oct 21, 2024 |
| 3 | Initial insider ownership | Oct 23, 2024 | Oct 21, 2024 |
| 8-K |
Current report
Auditor change
|
Oct 11, 2024 | Oct 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 20, 2024 | Sep 19, 2024 |
| 4 | Insider transaction | Aug 26, 2024 | Aug 23, 2024 |
| 144 | Notice of proposed sale | Aug 23, 2024 | — |
| 4 | Insider transaction | Aug 21, 2024 | Sep 6, 2023 |
| 4 | Insider transaction | Aug 21, 2024 | Sep 30, 2022 |
| SC 13D/A | Amended ownership over 5% (active) | Aug 21, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Aug 21, 2024 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 7, 2024 | Aug 7, 2024 |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 3 | Initial insider ownership | Jul 26, 2024 | Jul 16, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 16, 2024 | Jul 16, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 25, 2024 | Jun 19, 2024 |
| 4 | Insider transaction | Jun 24, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 24, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 24, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 24, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 24, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 8, 2024 | May 8, 2024 |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| ARS | Annual report to shareholders | Apr 25, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 25, 2024 | — |
| DEF 14A | Proxy statement | Apr 25, 2024 | Apr 25, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 6, 2024 | Mar 6, 2024 |
| 10-K | Annual report | Mar 6, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Feb 23, 2024 | Feb 22, 2024 |
| 4 | Insider transaction | Feb 23, 2024 | Feb 22, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 13, 2023 | Dec 8, 2023 |
| 4 | Insider transaction | Dec 4, 2023 | Dec 1, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 8, 2023 | Nov 8, 2023 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 4 | Insider transaction | Sep 7, 2023 | Sep 6, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Sep 7, 2023 | — |
| 4 | Insider transaction | Aug 15, 2023 | Aug 12, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 9, 2023 | Aug 9, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 424B5 | Prospectus supplement | Jul 6, 2023 | — |
| EFFECT | Filing | Jul 5, 2023 | — |
| CORRESP | Letter to the SEC | Jun 30, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 27, 2023 | — |
| S-8 | Employee stock plan registration | Jun 22, 2023 | — |
| S-3 | Shelf registration | Jun 22, 2023 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 20, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 13, 2023 | Jun 12, 2023 |
| 4 | Insider transaction | Jun 1, 2023 | May 31, 2023 |
| 4 | Insider transaction | May 30, 2023 | May 25, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 10, 2023 | May 10, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | — |
| PRE 14A | Preliminary proxy statement | Apr 19, 2023 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 17, 2023 | Mar 16, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 8, 2023 | Mar 8, 2023 |
| 10-K | Annual report | Mar 8, 2023 | Dec 31, 2022 |
| 4 | Insider transaction | Feb 17, 2023 | Feb 15, 2023 |
| 4 | Insider transaction | Feb 17, 2023 | Feb 15, 2023 |
| 8-K |
Current report
Officer or director change
|
Jan 5, 2023 | Jan 3, 2023 |
| 424B3 | Prospectus | Nov 17, 2022 | — |
| EFFECT | Filing | Nov 16, 2022 | — |
| CORRESP | Letter to the SEC | Nov 14, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 9, 2022 | — |
| S-3 | Shelf registration | Nov 3, 2022 | — |
| 10-Q | Quarterly report | Nov 2, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 2, 2022 | Nov 2, 2022 |
| SC 13G | Ownership over 5% (passive) | Oct 19, 2022 | — |
| D | Filing | Oct 14, 2022 | — |
| 424B5 | Prospectus supplement | Oct 11, 2022 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Oct 11, 2022 | Oct 10, 2022 |
| 4 | Insider transaction | Oct 3, 2022 | Sep 30, 2022 |
| 4 | Insider transaction | Oct 3, 2022 | Sep 30, 2022 |
| 3 | Initial insider ownership | Oct 3, 2022 | Sep 30, 2022 |
| SC 13D/A | Amended ownership over 5% (active) | Oct 3, 2022 | — |
| SC 13D/A | Amended ownership over 5% (active) | Oct 3, 2022 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Oct 3, 2022 | Sep 30, 2022 |
| CT ORDER | Filing | Sep 7, 2022 | — |
| 4 | Insider transaction | Aug 12, 2022 | Aug 9, 2022 |
| 3 | Initial insider ownership | Aug 12, 2022 | Aug 9, 2022 |
| 4 | Insider transaction | Aug 12, 2022 | Aug 12, 2022 |
| 4 | Insider transaction | Aug 12, 2022 | Aug 12, 2022 |
| 3 | Initial insider ownership | Aug 12, 2022 | Aug 11, 2022 |
| 10-Q | Quarterly report | Aug 10, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Aug 10, 2022 | Aug 8, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Jun 27, 2022 | — |
| 4 | Insider transaction | Jun 21, 2022 | Jun 16, 2022 |
| 4 | Insider transaction | Jun 21, 2022 | Jun 16, 2022 |
| 4 | Insider transaction | Jun 21, 2022 | Jun 16, 2022 |
| 4 | Insider transaction | Jun 21, 2022 | Jun 16, 2022 |
| 4 | Insider transaction | Jun 21, 2022 | Jun 16, 2022 |
| 4 | Insider transaction | Jun 21, 2022 | Jun 16, 2022 |
| 3 | Initial insider ownership | Jun 21, 2022 | Jun 15, 2022 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 21, 2022 | Jun 16, 2022 |
| 8-K |
Current report
Officer or director change
|
Jun 9, 2022 | Jun 3, 2022 |
| SC 13D/A | Amended ownership over 5% (active) | May 20, 2022 | — |
| SC 13D/A | Amended ownership over 5% (active) | May 20, 2022 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 19, 2022 | May 19, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 12, 2022 | May 12, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| DEFA14A | Additional proxy material | Apr 27, 2022 | — |
| DEF 14A | Proxy statement | Apr 27, 2022 | Jun 16, 2022 |
| 4 | Insider transaction | Apr 19, 2022 | Apr 15, 2022 |
| 3 | Initial insider ownership | Apr 19, 2022 | Apr 15, 2022 |
| 4 | Insider transaction | Apr 19, 2022 | Apr 15, 2022 |
| 3 | Initial insider ownership | Apr 19, 2022 | Apr 15, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 18, 2022 | Apr 14, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 15, 2022 | Apr 11, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 11, 2022 | Apr 5, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 8, 2022 | Apr 4, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 23, 2022 | Mar 23, 2022 |
| 4 | Insider transaction | Mar 16, 2022 | Mar 16, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- NAGE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Los Angeles, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1386570
- Former names
- ChromaDex Corp. (until Mar 10, 2025); CODY RESOURCES, INC. (until Jun 24, 2008)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.